Covid-19. To develop small synthetic chemical molecules as broadly active antiviral for the treatment of viral infections.
Active Definitive Contract Awarded Last action
- Contract number
- 75N93020C00054
- Awardee
-
The Leland Stanford Junior University UEI HJD6G4D6TJY5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $29,419,842
Award facts
- Opportunity
-
- 2020 NIAID Omnibus Broad Agency Announcement Pre-Solicitation · HHSNIHNIAIDBAA20201 · Posted Dec 11, 2019
- COVID-19: HHS-NIH-NIAID-BAA2020-1: Research Area 004, Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections and Emerging Infectious Diseases Award Notice · Posted Aug 28, 2020
- 2020 NIAID Omnibus Broad Agency Announcement Solicitation · Posted Jan 3, 2020
- Contract value 84% obligated
-
- $29,419,842.43 Current, with exercised options
- $34,898,846.43 Potential, with all options
- Completion date 64% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 23 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Palo Alto, CA 94305, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $5,197,478 | |
| Other Administrative Action | $0 | |
| Funding Only Action | -$3,311,855 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,893,799 | |
| Exercise an Option | $2,801,160 | |
| Funding Only Action | -$376,806 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $4,167,891 | |
| Exercise an Option | $4,788,101 | |
| Original award | $14,260,074 |
Show all 22
About this award
The National Institute of Allergy and Infectious Diseases awarded a definitive contract to The Leland Stanford Junior University for development of small synthetic chemical molecules as broadly active antivirals for treatment of viral infections on September 1, 2020, with a ceiling value of $34.9 million and ultimate completion date of May 31, 2030.
The contract carries cost-no-fee pricing. Place of performance is Palo Alto, California. The originating pre-solicitation, posted December 11, 2019, sought proposals for advanced vaccine and therapeutic candidates, medical countermeasures, and diagnostics targeting infectious diseases including Ebola, Zika, influenza, and antibiotic-resistant bacteria, with potential awards ranging from $2 million to $11.5 million per award across multiple research areas.
Stanford has engaged Inotiv, Inc. (preclinical and bioanalytical research), Curia Global Inc. doing business as Amri (pharmaceutical CDMO services including non-GMP manufacturing of compound candidates STF-2586 and STF-4326 and scale-up synthesis), and Acme Bioscience, Inc. (synthetic organic chemistry and medicinal chemistry for PI4K inhibitor backup compound series) as subcontractors supporting the PI-kinase inhibitor antiviral development effort.
Under Service Contract Inventory reporting, Stanford invoiced $13.5 million in FY2025 across 16.7 FTEs and 34,781 contractor hours, with 40 percent of hours subcontracted. Derived government-paid hourly rates rose from $104.04/hr in FY2024 to $388.79/hr in FY2025, reflecting the contract's shift toward higher-value synthesis and manufacturing activities. Prior-year invoicing ranged from $112 thousand (FY2020) to $2.9 million (FY2021), indicating significant acceleration in work scope and labor demand beginning in FY2025.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Curia Global Inc. | $38,300 | |
| Curia Global Inc. | $171,900 | |
| Inotiv, Inc. | $80,172 | |
| Inotiv, Inc. | $166,622 | |
| Curia Global Inc. | $207,900 | |
| Aravasc, Inc. | $80,132 | |
| Inotiv, Inc. | $19,760 | |
| Inotiv, Inc. | $16,000 | |
| Inotiv, Inc. | $432,691 | |
| Inotiv, Inc. | $27,200 | |
| Inotiv, Inc. | $2,520 | |
| Aravasc, Inc. | $108,800 | |
| Curia Global Inc. | $844,600 | |
| Acme Bioscience, Inc. | $245,200 | |
| Acme Bioscience, Inc. | $186,400 | |
| Curia Global Inc. | $56,600 | |
| Inotiv, Inc. | $2,347 | |
| Inotiv, Inc. | $380,078 | |
| Inotiv, Inc. | $5,250 | |
| Inotiv, Inc. | $75,423 | |
| Curia Global Inc. | $337,600 | |
| Inotiv, Inc. | $3,009,894 | |
| Inotiv, Inc. | $225,574 | |
| Inotiv, Inc. | $73,220 | |
| Curia Global Inc. | $34,500 | |
| Acme Bioscience, Inc. | $116,575 | |
| Curia Global Inc. | $206,500 | |
| Curia Global Inc. | $116,000 | |
| Curia Global Inc. | $32,500 | |
| Curia Global Inc. | $182,583 |
Show all 30
Quick answers
Who was awarded contract 75N93020C00054?
75N93020C00054 was awarded to The Leland Stanford Junior University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2020.
How much is contract 75N93020C00054 worth?
The government has obligated $29,419,842 on 75N93020C00054. Its potential value, with all options, is $34,898,846.
Was contract 75N93020C00054 competed?
The extent of competition for 75N93020C00054 was full and open competition. The government received 23 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award